 | • レポートコード：GIR-2104Z11685 • 出版社/出版日：GlobalInfoResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、104ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療・医薬品 |
| Single User | ￥504,600 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥756,900 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,009,200 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、ヒト用狂犬病ワクチンのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。ヒト用狂犬病ワクチンの種類別市場規模（予防ワクチン、緊急狂犬病ワクチン）、用途別市場規模（暴露前予防、暴露後予防）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・ヒト用狂犬病ワクチンの市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Novartis、Sanofi、GlaxoSmithKline、Merck、Chengda、Yisheng、Prcmise、VACN、Changsheng、BCHT、Hissen ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：予防ワクチン、緊急狂犬病ワクチン ・用途別分析2016年-2026年：暴露前予防、暴露後予防 ・ヒト用狂犬病ワクチンの北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・ヒト用狂犬病ワクチンのヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・ヒト用狂犬病ワクチンのアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・ヒト用狂犬病ワクチンの南米市場規模2016年-2026年：ブラジル、アルゼンチン ・ヒト用狂犬病ワクチンの中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Rabies Vaccine for Humans market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Rabies Vaccine for Humans size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Rabies Vaccine for Humans market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Rabies Vaccine for Humans market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Preventative Vaccine
Emergency Rabies Vaccine
Market segment by Application can be divided into
Pre-exposure prophylaxis
Post-exposure prophylaxis
The key market players for global Rabies Vaccine for Humans market are listed below:
Novartis
Sanofi
GlaxoSmithKline
Merck
Chengda
Yisheng
Prcmise
VACN
Changsheng
BCHT
Hissen
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
1 Market Overview
1.1 Rabies Vaccine for Humans Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Rabies Vaccine for Humans Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Preventative Vaccine
1.2.3 Emergency Rabies Vaccine
1.3 Market Analysis by Application
1.3.1 Overview: Global Rabies Vaccine for Humans Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Pre-exposure prophylaxis
1.3.3 Post-exposure prophylaxis
1.4 Global Rabies Vaccine for Humans Market Size & Forecast
1.4.1 Global Rabies Vaccine for Humans Sales in Value (2016-2026))
1.4.2 Global Rabies Vaccine for Humans Sales in Volume (2016-2026)
1.4.3 Global Rabies Vaccine for Humans Price by Type (2016-2026) & (USD/Unit)
1.5 Global Rabies Vaccine for Humans Production Capacity Analysis
1.5.1 Global Rabies Vaccine for Humans Total Production Capacity (2016-2026)
1.5.2 Global Rabies Vaccine for Humans Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Rabies Vaccine for Humans Market Drivers
1.6.2 Rabies Vaccine for Humans Market Restraints
1.6.3 Rabies Vaccine for Humans Trends Analysis
2 Manufacturers Profiles
2.1 Novartis
2.1.1 Novartis Details
2.1.2 Novartis Major Business
2.1.3 Novartis Rabies Vaccine for Humans Product and Services
2.1.4 Novartis Rabies Vaccine for Humans Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 Sanofi
2.2.1 Sanofi Details
2.2.2 Sanofi Major Business
2.2.3 Sanofi Rabies Vaccine for Humans Product and Services
2.2.4 Sanofi Rabies Vaccine for Humans Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 GlaxoSmithKline
2.3.1 GlaxoSmithKline Details
2.3.2 GlaxoSmithKline Major Business
2.3.3 GlaxoSmithKline Rabies Vaccine for Humans Product and Services
2.3.4 GlaxoSmithKline Rabies Vaccine for Humans Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 Merck
2.4.1 Merck Details
2.4.2 Merck Major Business
2.4.3 Merck Rabies Vaccine for Humans Product and Services
2.4.4 Merck Rabies Vaccine for Humans Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 Chengda
2.5.1 Chengda Details
2.5.2 Chengda Major Business
2.5.3 Chengda Rabies Vaccine for Humans Product and Services
2.5.4 Chengda Rabies Vaccine for Humans Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.6 Yisheng
2.6.1 Yisheng Details
2.6.2 Yisheng Major Business
2.6.3 Yisheng Rabies Vaccine for Humans Product and Services
2.6.4 Yisheng Rabies Vaccine for Humans Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.7 Prcmise
2.7.1 Prcmise Details
2.7.2 Prcmise Major Business
2.7.3 Prcmise Rabies Vaccine for Humans Product and Services
2.7.4 Prcmise Rabies Vaccine for Humans Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.8 VACN
2.8.1 VACN Details
2.8.2 VACN Major Business
2.8.3 VACN Rabies Vaccine for Humans Product and Services
2.8.4 VACN Rabies Vaccine for Humans Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.9 Changsheng
2.9.1 Changsheng Details
2.9.2 Changsheng Major Business
2.9.3 Changsheng Rabies Vaccine for Humans Product and Services
2.9.4 Changsheng Rabies Vaccine for Humans Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.10 BCHT
2.10.1 BCHT Details
2.10.2 BCHT Major Business
2.10.3 BCHT Rabies Vaccine for Humans Product and Services
2.10.4 BCHT Rabies Vaccine for Humans Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.11 Hissen
2.11.1 Hissen Details
2.11.2 Hissen Major Business
2.11.3 Hissen Rabies Vaccine for Humans Product and Services
2.11.4 Hissen Rabies Vaccine for Humans Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Rabies Vaccine for Humans Sales by Manufacturer
3.1 Global Rabies Vaccine for Humans Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Rabies Vaccine for Humans Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Rabies Vaccine for Humans
3.4 Market Concentration Rate
3.4.1 Top 3 Rabies Vaccine for Humans Manufacturer Market Share
3.4.2 Top 6 Rabies Vaccine for Humans Manufacturer Market Share
3.5 Global Rabies Vaccine for Humans Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Rabies Vaccine for Humans Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Rabies Vaccine for Humans Market Size by Region
4.1.1 Global Rabies Vaccine for Humans Sales in Volume by Region (2016-2026)
4.1.2 Global Rabies Vaccine for Humans Revenue by Region (2016-2026)
4.2 North America Rabies Vaccine for Humans Revenue (2016-2026)
4.3 Europe Rabies Vaccine for Humans Revenue (2016-2026)
4.4 Asia-Pacific Rabies Vaccine for Humans Revenue (2016-2026)
4.5 South America Rabies Vaccine for Humans Revenue (2016-2026)
4.6 Middle East and Africa Rabies Vaccine for Humans Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Rabies Vaccine for Humans Sales in Volume by Type (2016-2026)
5.2 Global Rabies Vaccine for Humans Revenue by Type (2016-2026)
5.3 Global Rabies Vaccine for Humans Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Rabies Vaccine for Humans Sales in Volume by Application (2016-2026)
6.2 Global Rabies Vaccine for Humans Revenue by Application (2016-2026)
6.3 Global Rabies Vaccine for Humans Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Rabies Vaccine for Humans Sales by Type (2016-2026)
7.2 North America Rabies Vaccine for Humans Sales by Application (2016-2026)
7.3 North America Rabies Vaccine for Humans Market Size by Country
7.3.1 North America Rabies Vaccine for Humans Sales in Volume by Country (2016-2026)
7.3.2 North America Rabies Vaccine for Humans Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Rabies Vaccine for Humans Sales by Type (2016-2026)
8.2 Europe Rabies Vaccine for Humans Sales by Application (2016-2026)
8.3 Europe Rabies Vaccine for Humans Market Size by Country
8.3.1 Europe Rabies Vaccine for Humans Sales in Volume by Country (2016-2026)
8.3.2 Europe Rabies Vaccine for Humans Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Rabies Vaccine for Humans Sales by Type (2016-2026)
9.2 Asia-Pacific Rabies Vaccine for Humans Sales by Application (2016-2026)
9.3 Asia-Pacific Rabies Vaccine for Humans Market Size by Region
9.3.1 Asia-Pacific Rabies Vaccine for Humans Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Rabies Vaccine for Humans Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Rabies Vaccine for Humans Sales by Type (2016-2026)
10.2 South America Rabies Vaccine for Humans Sales by Application (2016-2026)
10.3 South America Rabies Vaccine for Humans Market Size by Country
10.3.1 South America Rabies Vaccine for Humans Sales in Volume by Country (2016-2026)
10.3.2 South America Rabies Vaccine for Humans Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Rabies Vaccine for Humans Sales by Type (2016-2026)
11.2 Middle East & Africa Rabies Vaccine for Humans Sales by Application (2016-2026)
11.3 Middle East & Africa Rabies Vaccine for Humans Market Size by Country
11.3.1 Middle East & Africa Rabies Vaccine for Humans Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Rabies Vaccine for Humans Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Rabies Vaccine for Humans Typical Distributors
12.3 Rabies Vaccine for Humans Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Rabies Vaccine for Humans Revenue by Type, (USD Million), 2021-2026
Table 2. Global Rabies Vaccine for Humans Revenue by Application, (USD Million), 2021-2026
Table 3. Novartis Basic Information, Manufacturing Base and Competitors
Table 4. Novartis Major Business
Table 5. Novartis Rabies Vaccine for Humans Product and Services
Table 6. Novartis Rabies Vaccine for Humans Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Sanofi Basic Information, Manufacturing Base and Competitors
Table 8. Sanofi Major Business
Table 9. Sanofi Rabies Vaccine for Humans Product and Services
Table 10. Sanofi Rabies Vaccine for Humans Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 12. GlaxoSmithKline Major Business
Table 13. GlaxoSmithKline Rabies Vaccine for Humans Product and Services
Table 14. GlaxoSmithKline Rabies Vaccine for Humans Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Merck Basic Information, Manufacturing Base and Competitors
Table 16. Merck Major Business
Table 17. Merck Rabies Vaccine for Humans Product and Services
Table 18. Merck Rabies Vaccine for Humans Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Chengda Basic Information, Manufacturing Base and Competitors
Table 20. Chengda Major Business
Table 21. Chengda Rabies Vaccine for Humans Product and Services
Table 22. Chengda Rabies Vaccine for Humans Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Yisheng Basic Information, Manufacturing Base and Competitors
Table 24. Yisheng Major Business
Table 25. Yisheng Rabies Vaccine for Humans Product and Services
Table 26. Yisheng Rabies Vaccine for Humans Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Prcmise Basic Information, Manufacturing Base and Competitors
Table 28. Prcmise Major Business
Table 29. Prcmise Rabies Vaccine for Humans Product and Services
Table 30. Prcmise Rabies Vaccine for Humans Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. VACN Basic Information, Manufacturing Base and Competitors
Table 32. VACN Major Business
Table 33. VACN Rabies Vaccine for Humans Product and Services
Table 34. VACN Rabies Vaccine for Humans Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Changsheng Basic Information, Manufacturing Base and Competitors
Table 36. Changsheng Major Business
Table 37. Changsheng Rabies Vaccine for Humans Product and Services
Table 38. Changsheng Rabies Vaccine for Humans Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. BCHT Basic Information, Manufacturing Base and Competitors
Table 40. BCHT Major Business
Table 41. BCHT Rabies Vaccine for Humans Product and Services
Table 42. BCHT Rabies Vaccine for Humans Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Hissen Basic Information, Manufacturing Base and Competitors
Table 44. Hissen Major Business
Table 45. Hissen Rabies Vaccine for Humans Product and Services
Table 46. Hissen Rabies Vaccine for Humans Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 47. Global Rabies Vaccine for Humans Sales by Manufacturer (2019-2021e) & (K Units)
Table 48. Global Rabies Vaccine for Humans Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 49. Market Position of Manufacturers in Rabies Vaccine for Humans, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 50. Global Rabies Vaccine for Humans Production Capacity by Company, (K Units): 2020 VS 2021
Table 51. Head Office and Rabies Vaccine for Humans Production Site of Key Manufacturer
Table 52. Global Rabies Vaccine for Humans Sales by Region (2016-2021e) & (K Units)
Table 53. Global Rabies Vaccine for Humans Sales by Region (2021-2026) & (K Units)
Table 54. Global Rabies Vaccine for Humans Revenue by Region (2016-2021e) & (USD Million)
Table 55. Global Rabies Vaccine for Humans Revenue by Region (2021-2026) & (USD Million)
Table 56. Global Rabies Vaccine for Humans Sales by Type (2016-2021e) & (K Units)
Table 57. Global Rabies Vaccine for Humans Sales by Type (2021-2026) & (K Units)
Table 58. Global Rabies Vaccine for Humans Revenue by Type (2016-2021e) & (USD Million)
Table 59. Global Rabies Vaccine for Humans Revenue by Type (2021-2026) & (USD Million)
Table 60. Global Rabies Vaccine for Humans Price by Type (2016-2021e) & (USD/Unit)
Table 61. Global Rabies Vaccine for Humans Price by Type (2021-2026) & (USD/Unit)
Table 62. Global Rabies Vaccine for Humans Sales by Application (2016-2021e) & (K Units)
Table 63. Global Rabies Vaccine for Humans Sales by Application (2021-2026) & (K Units)
Table 64. Global Rabies Vaccine for Humans Revenue by Application (2016-2021e) & (USD Million)
Table 65. Global Rabies Vaccine for Humans Revenue by Application (2021-2026) & (USD Million)
Table 66. Global Rabies Vaccine for Humans Price by Application (2016-2021e) & (USD/Unit)
Table 67. Global Rabies Vaccine for Humans Price by Application (2021-2026) & (USD/Unit)
Table 68. North America Rabies Vaccine for Humans Sales by Country (2016-2021e) & (K Units)
Table 69. North America Rabies Vaccine for Humans Sales by Country (2021-2026) & (K Units)
Table 70. North America Rabies Vaccine for Humans Revenue by Country (2016-2021e) & (USD Million)
Table 71. North America Rabies Vaccine for Humans Revenue by Country (2021-2026) & (USD Million)
Table 72. North America Rabies Vaccine for Humans Sales by Type (2016-2021e) & (K Units)
Table 73. North America Rabies Vaccine for Humans Sales by Type (2021-2026) & (K Units)
Table 74. North America Rabies Vaccine for Humans Sales by Application (2016-2021e) & (K Units)
Table 75. North America Rabies Vaccine for Humans Sales by Application (2021-2026) & (K Units)
Table 76. Europe Rabies Vaccine for Humans Sales by Country (2016-2021e) & (K Units)
Table 77. Europe Rabies Vaccine for Humans Sales by Country (2021-2026) & (K Units)
Table 78. Europe Rabies Vaccine for Humans Revenue by Country (2016-2021e) & (USD Million)
Table 79. Europe Rabies Vaccine for Humans Revenue by Country (2021-2026) & (USD Million)
Table 80. Europe Rabies Vaccine for Humans Sales by Type (2016-2021e) & (K Units)
Table 81. Europe Rabies Vaccine for Humans Sales by Type (2021-2026) & (K Units)
Table 82. Europe Rabies Vaccine for Humans Sales by Application (2016-2021e) & (K Units)
Table 83. Europe Rabies Vaccine for Humans Sales by Application (2021-2026) & (K Units)
Table 84. Asia-Pacific Rabies Vaccine for Humans Sales by Region (2016-2021e) & (K Units)
Table 85. Asia-Pacific Rabies Vaccine for Humans Sales by Region (2021-2026) & (K Units)
Table 86. Asia-Pacific Rabies Vaccine for Humans Revenue by Region (2016-2021e) & (USD Million)
Table 87. Asia-Pacific Rabies Vaccine for Humans Revenue by Region (2021-2026) & (USD Million)
Table 88. Asia-Pacific Rabies Vaccine for Humans Sales by Type (2016-2021e) & (K Units)
Table 89. Asia-Pacific Rabies Vaccine for Humans Sales by Type (2021-2026) & (K Units)
Table 90. Asia-Pacific Rabies Vaccine for Humans Sales by Application (2016-2021e) & (K Units)
Table 91. Asia-Pacific Rabies Vaccine for Humans Sales by Application (2021-2026) & (K Units)
Table 92. South America Rabies Vaccine for Humans Sales by Country (2016-2021e) & (K Units)
Table 93. South America Rabies Vaccine for Humans Sales by Country (2021-2026) & (K Units)
Table 94. South America Rabies Vaccine for Humans Revenue by Country (2016-2021e) & (USD Million)
Table 95. South America Rabies Vaccine for Humans Revenue by Country (2021-2026) & (USD Million)
Table 96. South America Rabies Vaccine for Humans Sales by Type (2016-2021e) & (K Units)
Table 97. South America Rabies Vaccine for Humans Sales by Type (2021-2026) & (K Units)
Table 98. South America Rabies Vaccine for Humans Sales by Application (2016-2021e) & (K Units)
Table 99. South America Rabies Vaccine for Humans Sales by Application (2021-2026) & (K Units)
Table 100. Middle East & Africa Rabies Vaccine for Humans Sales by Country (2016-2021e) & (K Units)
Table 101. Middle East & Africa Rabies Vaccine for Humans Sales by Country (2021-2026) & (K Units)
Table 102. Middle East & Africa Rabies Vaccine for Humans Revenue by Country (2016-2021e) & (USD Million)
Table 103. Middle East & Africa Rabies Vaccine for Humans Revenue by Country (2021-2026) & (USD Million)
Table 104. Middle East & Africa Rabies Vaccine for Humans Sales by Type (2016-2021e) & (K Units)
Table 105. Middle East & Africa Rabies Vaccine for Humans Sales by Type (2021-2026) & (K Units)
Table 106. Middle East & Africa Rabies Vaccine for Humans Sales by Application (2016-2021e) & (K Units)
Table 107. Middle East & Africa Rabies Vaccine for Humans Sales by Application (2021-2026) & (K Units)
Table 108. Direct Channel Pros & Cons
Table 109. Indirect Channel Pros & Cons
Table 110. Rabies Vaccine for Humans Typical Distributors
Table 111. Rabies Vaccine for Humans Typical Customers
List of Figures
Figure 1. Rabies Vaccine for Humans Picture
Figure 2. Global Rabies Vaccine for Humans Sales Market Share by Type in 2020
Figure 3. Preventative Vaccine
Figure 4. Emergency Rabies Vaccine
Figure 5. Global Rabies Vaccine for Humans Sales Market Share by Application in 2020
Figure 6. Pre-exposure prophylaxis
Figure 7. Post-exposure prophylaxis
Figure 8. Global Rabies Vaccine for Humans Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 9. Global Rabies Vaccine for Humans Market Size and Forecast (2016-2026) & (USD Million)
Figure 10. United States Rabies Vaccine for Humans Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 11. Canada Rabies Vaccine for Humans Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 12. Mexico Rabies Vaccine for Humans Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 13. Germany Rabies Vaccine for Humans Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 14. France Rabies Vaccine for Humans Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 15. United Kingdom Rabies Vaccine for Humans Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. Russia Rabies Vaccine for Humans Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. Italy Rabies Vaccine for Humans Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. China Rabies Vaccine for Humans Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. Japan Rabies Vaccine for Humans Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. Korea Rabies Vaccine for Humans Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. India Rabies Vaccine for Humans Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. Southeast Asia Rabies Vaccine for Humans Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. Australia Rabies Vaccine for Humans Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. Brazil Rabies Vaccine for Humans Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Egypt Rabies Vaccine for Humans Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Saudi Arabia Rabies Vaccine for Humans Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. South Africa Rabies Vaccine for Humans Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. Turkey Rabies Vaccine for Humans Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. Global Rabies Vaccine for Humans Sales (2016-2026) & (K Units)
Figure 30. Global Rabies Vaccine for Humans Production Capacity (2016-2026) & (K Units)
Figure 31. Global Rabies Vaccine for Humans Production Capacity by Geographic Region: 2020 VS 2021
Figure 32. Rabies Vaccine for Humans Market Drivers
Figure 33. Rabies Vaccine for Humans Market Restraints
Figure 34. Rabies Vaccine for Humans Market Trends
Figure 35. Global Rabies Vaccine for Humans Sales Market Share by Manufacturer in 2020
Figure 36. Global Rabies Vaccine for Humans Revenue Market Share by Manufacturer in 2020
Figure 37. Rabies Vaccine for Humans Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 38. Top 3 Rabies Vaccine for Humans Manufacturer (Revenue) Market Share in 2020
Figure 39. Top 6 Rabies Vaccine for Humans Manufacturer (Revenue) Market Share in 2020
Figure 40. Global Rabies Vaccine for Humans Sales Market Share by Region (2016-2026)
Figure 41. Global Rabies Vaccine for Humans Revenue Market Share by Region (2016-2026)
Figure 42. North America Rabies Vaccine for Humans Revenue (2016-2026) & (USD Million)
Figure 43. Europe Rabies Vaccine for Humans Revenue (2016-2026) & (USD Million)
Figure 44. Asia-Pacific Rabies Vaccine for Humans Revenue (2016-2026) & (USD Million)
Figure 45. South America Rabies Vaccine for Humans Revenue (2016-2026) & (USD Million)
Figure 46. Middle East & Africa Rabies Vaccine for Humans Revenue (2016-2026) & (USD Million)
Figure 47. Global Rabies Vaccine for Humans Sales Market Share by Type (2016-2026)
Figure 48. Global Rabies Vaccine for Humans Revenue Market Share by Type (2016-2026)
Figure 49. Global Rabies Vaccine for Humans Price by Type (2016-2026) & (USD/Unit)
Figure 50. Global Rabies Vaccine for Humans Sales Market Share by Application (2016-2026)
Figure 51. Global Rabies Vaccine for Humans Revenue Market Share by Application (2016-2026)
Figure 52. Global Rabies Vaccine for Humans Price by Application (2016-2026) & (USD/Unit)
Figure 53. North America Rabies Vaccine for Humans Sales Market Share by Country (2016-2026)
Figure 54. North America Rabies Vaccine for Humans Revenue Market Share by Country (2016-2026)
Figure 55. North America Rabies Vaccine for Humans Sales Market Share by Type (2016-2026)
Figure 56. North America Rabies Vaccine for Humans Sales Market Share by Application (2016-2026)
Figure 57. Europe Rabies Vaccine for Humans Sales Market Share by Country (2016-2026)
Figure 58. Europe Rabies Vaccine for Humans Revenue Market Share by Country (2016-2026)
Figure 59. Europe Rabies Vaccine for Humans Sales Market Share by Type (2016-2026)
Figure 60. Europe Rabies Vaccine for Humans Sales Market Share by Application (2016-2026)
Figure 61. Asia-Pacific Rabies Vaccine for Humans Sales Market Share by Region (2016-2026)
Figure 62. Asia-Pacific Rabies Vaccine for Humans Revenue Market Share by Region (2016-2026)
Figure 63. Asia-Pacific Rabies Vaccine for Humans Sales Market Share by Region (2016-2026)
Figure 64. Asia-Pacific Rabies Vaccine for Humans Sales Market Share by Application (2016-2026)
Figure 65. South America Rabies Vaccine for Humans Sales Market Share by Country (2016-2026)
Figure 66. South America Rabies Vaccine for Humans Revenue Market Share by Country (2016-2026)
Figure 67. South America Rabies Vaccine for Humans Sales Market Share by Type (2016-2026)
Figure 68. South America Rabies Vaccine for Humans Sales Market Share by Application (2016-2026)
Figure 69. Middle East & Africa Rabies Vaccine for Humans Sales Market Share by Country (2016-2026)
Figure 70. Middle East & Africa Rabies Vaccine for Humans Revenue Market Share by Country (2016-2026)
Figure 71. Middle East & Africa Rabies Vaccine for Humans Sales Market Share by Type (2016-2026)
Figure 72. Middle East & Africa Rabies Vaccine for Humans Sales Market Share by Application (2016-2026)
Figure 73. Sales Channel: Direct Channel vs Indirect Channel
Figure 74. Methodology
Figure 75. Research Process and Data Source
世界の肺炎球菌多価ワクチン市場 2021：企業別、地域別、種類・用途別 The Pneumococcal Vaccine Polyvalent market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade…- 世界のワクチン受託製造市場 2021：企業別、地域別、種類・用途別 The Vaccine Contract Manufacturing market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade …
- 世界のクロストリジウムワクチン市場 2021：企業別、地域別、種類・用途別 The Clostridium Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations…
- 世界の成人用ワクチン市場 2021：企業別、地域別、種類・用途別 The Adult Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, rece…
- 世界のBCG結核（TB）ワクチン市場 2021：企業別、地域別、種類・用途別 The BCG Tuberculosis (TB) Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade r…